Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Annals of Surgical Oncology
Erschienen in: Annals of Surgical Oncology 10/2017

01.08.2017 | Breast Oncology

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options

verfasst von: Sarah A. McLaughlin, MD, Sarah M. DeSnyder, MD, Suzanne Klimberg, MD, PhD, Michael Alatriste, LMT, CLT, Francesco Boccardo, MD, PhD, FACS, Mark L. Smith, MD, FACS, Alicia C. Staley, MBA, MS, BS, Paul T. R. Thiruchelvam, BSc, MD, PhD, FRCS, Nancy A. Hutchison, MD, CLT-LANA, Jane Mendez, MD, Fiona MacNeill, FRCS, MD, FEBS, Frank Vicini, MD, FACR, FABS, Stanley G. Rockson, MD, Sheldon M. Feldman, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Excerpt

The American Society of Breast Surgeons (ASBrS) recognizes lymphedema as a significant side effect of breast cancer treatment. Therefore, the ASBrS convened an international, multidisciplinary expert panel to review current data and guidelines on all aspects of lymphedema diagnosis and management to acknowledge the gravity of this public health issue facing breast cancer survivors. The Panel sought to collate clear and meaningful recommendations for providers regarding lymphedema diagnosis, treatment, and prevention. Diagnosis, education, and future directions were discussed in Part 1. Part 2 focuses on prevention and treatment. …
Literatur
1.
McLaughlin SA, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg. 2013;216(3):380–9.
2.
McLaughlin SA, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26:5220–6.CrossRefPubMedPubMedCentral
3.
Showalter SL, et al. Lifestyle risk factors associated with arm swelling among women with breast cancer. Ann Surg Oncol. 2013;20:842–9.CrossRefPubMed
4.
Kilbreath SL, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29–36.CrossRefPubMed
5.
Ferguson, CM, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34:691–8.CrossRefPubMed
6.
The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology. 2016;49:170–84.
7.
8.
Pinto BM, Maruyama NC. Exercise in the rehabilitation of breast cancer survivors. Psychooncology. 1999;8:191–206.CrossRefPubMed
9.
Pinto BM, et al. Psychological and fitness changes associated with exercise participation among women with breast cancer. Psychooncology. 2003;12:118–26.CrossRefPubMed
10.
Rock CL, Demark-Wahnefried W. Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr. 2002;132(11 Suppl):3504S–7S.PubMed
11.
Schmitz KH, et al. Weight-lifting in women with breast cancer-related lymphedema. N Engl J Med. 2009;361:664–73.CrossRefPubMed
12.
13.
Di Blasio A, et al. Physical exercises for breast cancer survivors: effects of 10 weeks of training on upper limb circumferences. J Phys Ther Sci. 2016;28:2778–84.CrossRefPubMedPubMedCentral
14.
Courneya KS, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25:4396–404.CrossRefPubMed
15.
Hayes SC, Reul-Hirche H, Turner J. Exercise and secondary lymphedema: safety, potential benefits, and research issues. Med Sci Sports Exer. 2009;41:483–9.CrossRefPubMed
16.
Portela AL, et al. Feasibility of an exercise program for Puerto Rican women who are breast cancer survivors. Rehab Oncol. 2008;26:20–31.PubMedPubMedCentral
17.
18.
19.
Lymphedema (Internet). Susan G. Komen, Dallas, TX (2017). Accessed 6 February 2017.
20.
21.
Brown JC, Troxel AB, Schmitz KH. Safety of weightlifting among women with or at risk for breast cancer-related lymphedema: musculoskeletal injuries and health care use in a weightlifting rehabilitation trial. Oncologist. 2012;17:1120–8.CrossRefPubMedPubMedCentral
22.
Ahmed M, et al. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016;103:170–8.CrossRefPubMed
23.
Beek MA, et al. Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status. Breast Cancer Res Treat. 2016;158:421–32.CrossRefPubMed
24.
Boneti C, et al. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy. Minerva Ginecol. 2012;64:421–30.PubMed
25.
Boneti C, et al. Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg. 2009;198:482–7.CrossRefPubMed
26.
Gebruers N, Tjalma WA. Clinical feasibility of axillary reverse mapping and its influence on breast cancer-related lymphedema: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;200:117–22.CrossRefPubMed
27.
Han C, et al. The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis of prospective studies. PloS One. 2016;11:e0150285.CrossRefPubMedPubMedCentral
28.
Noguchi M, et al. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer. Eur J Surg Oncol. 2016;42:650–6.CrossRefPubMed
29.
30.
Tummel E, et al. Does axillary reverse mapping prevent lymphedema after lymphadenectomy? Ann Surg. 2017;265:987–92.CrossRefPubMed
31.
Yue T, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer. 2015;15:301–6.CrossRefPubMed
32.
Boccardo F, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16:703–8.CrossRefPubMed
33.
Boccardo FM, et al. Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol. 2011;18:2500–5.CrossRefPubMed
34.
Boccardo F, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery. 2014;34:421–4.CrossRefPubMed
35.
Feldman S, et al. Single-institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. Ann Surg Oncol. 2015;22:3296–301.CrossRefPubMed
36.
Gomberawalla A, VJ, Borden B, Rohde C, Ascherman J, Taback B, et al. Lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. In: Poster presentation 39th Annual San Antonio Breast Cancer Symposium P2-01-14; 2016.
37.
38.
Szolnoky G, Dobozy A, Kemeny L. Towards an effective management of chronic lymphedema. Clin Dermatol. 2014;32:685–91.CrossRefPubMed
39.
Wanchai A, Armer JM, Stewart BR, Lasinski BB Breast cancer-related lymphedema: a literature review for clinical practice. Int J Nurs Sci. 2016;3:202–7.
40.
Randheer S, et al. Comprehensive decongestive therapy in postmastectomy lymphedema: an Indian perspective. Indian J Cancer. 2011;48:397–402.CrossRefPubMed
41.
42.
43.
Lasinski BB, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R J Injury Function Rehabil. 2012;4:580–601.
44.
Feldman JL, et al. Intermittent pneumatic compression therapy: a systematic review. Lymphology. 2012;45:13–25.PubMed
45.
Rodrick JR, et al. Complementary, alternative, and other noncomplete decongestive therapy treatment methods in the management of lymphedema: a systematic search and review. PM R J Injury Function Rehabil. 2014;6:250–74; quiz 274
46.
Masia J, Pons G, Nardulli ML. Combined surgical treatment in breast cancer-related lymphedema. J Reconstr Microsurg. 2016;32:16–27.CrossRefPubMed
47.
Feldman MG, et al. Lymphangiographic studies in obstructive lymphedema of the upper extremity. Surgery. 1966;59:935–43.PubMed
48.
Yoo JN, et al. Validity of quantitative lymphoscintigraphy as a lymphedema assessment tool for patients with breast cancer. Ann Rehabil Med. 2015;39:931–40.CrossRefPubMedPubMedCentral
49.
Hwang JH, et al. Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema. Lymphology. 2007;40:172–6.PubMed
50.
Stanton AW, et al. Forearm blood flow measured by venous occlusion plethysmography in healthy subjects and in women with postmastectomy oedema. Vasc Med. 1998;3:3–8.CrossRefPubMed
51.
Mihara M, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PloS One. 2012;7:e38182.CrossRefPubMedPubMedCentral
52.
53.
Boccardo F, et al. Lymphatic microsurgery to treat lymphedema: techniques and indications for better results. Ann Plast Surg. 2013;71:191–5.CrossRefPubMed
54.
Mihara M, et al. Upper-limb lymphedema treated aesthetically with lymphaticovenous anastomosis using indocyanine green lymphography and noncontact vein visualization. J Reconstr Microsurg. 2012;28:327–32.CrossRefPubMed
55.
Becker C. Autologous lymph node transfers. J Reconstr Microsurg. 2016;32:28–33.PubMed
56.
Baumeister RG, et al. Microsurgical lymphatic vessel transplantation. J Reconstr Microsurg. 2016;32:34–41.PubMed
57.
Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28:609–13.CrossRefPubMed
58.
59.
Loh CY, et al. The 5th World Symposium for Lymphedema Surgery: recent updates in lymphedema surgery and setting up of a global knowledge exchange platform. J Surg Oncol. 2017;115:6–12.CrossRefPubMed
60.
Yamamoto T, et al. Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plast Reconstr Surg. 2011;128:941–7.CrossRefPubMed
61.
Yamamoto T, et al. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg. 2011;127:1979–86.CrossRefPubMed
62.
63.
Tobbia, D, et al. Lymphedema development and lymphatic function following lymph node excision in sheep. J Vasc Res. 2009;46:426–34.CrossRefPubMed
64.
65.
Slavin SA, et al. An investigation of lymphatic function following free-tissue transfer. Plast Reconstr Surg. 1997;99:730–41; discussion 742–3CrossRefPubMed
66.
Adair TH, et al. Quantitation of changes in lymph protein concentration during lymph node transit. Am J Physiol. 1982;243:H351–9.PubMed
67.
Adair TH, Guyton AC. Modification of lymph by lymph nodes: II. Effect of increased lymph node venous blood pressure. Am J Physiol. 1983;245:H616–22.PubMed
68.
Adair TH, Guyton AC. Modification of lymph by lymph nodes: III. Effect of increased lymph hydrostatic pressure. Am J Physiol. 1985; 249(4): H777–82.PubMed
69.
Ito R, et al. Proposed pathway and mechanism of vascularized lymph node flaps. Gynecol Oncol. 2016;141:182–8.CrossRefPubMed
70.
Miranda Garces M, et al. A comprehensive review of the natural lymphaticovenous communications and their role in lymphedema surgery. J Surg Oncol. 2016;113:374–80.CrossRefPubMed
71.
72.
Huang JJ, et al. Lymph node transplantation decreases swelling and restores immune responses in a transgenic model of lymphedema. PloS One. 2016;11:e0168259.CrossRefPubMedPubMedCentral
73.
Lahteenvuo M, et al. Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation. 2011;123:613–20.CrossRefPubMed
74.
Viitanen TP, et al. Lymphatic vessel function and lymphatic growth factor secretion after microvascular lymph node transfer in lymphedema patients. Plast Reconstr Surg Global Open. 2013;1:1–9.CrossRefPubMedPubMedCentral
75.
Skobe M, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med. 2001;7:192–8.CrossRefPubMed
76.
Dayan JH, et al. The use of magnetic resonance angiography in vascularized groin lymph node transfer: an anatomic study. J Reconstr Microsurg. 2014;30:41–5.CrossRefPubMed
77.
Dayan JH, Dayan E, Smith ML. Reverse lymphatic mapping: a new technique for maximizing safety in vascularized lymph node transfer. Plast Reconstr Surg. 2015;135:277–85.CrossRefPubMed
78.
Chowdhry MRW, Griffiths M. Lymphatic mapping and preoperative imaging in the management of postmastectomy lymphoedema. Gland Surg. 2016;5:187–96.PubMedPubMedCentral
79.
Mardonado AA, Chen R, Chang DW. The use of supraclavicular free flap with vascularized lymph node transfer for treatment of lymphedema: a prospective study of 100 consecutive cases. J Surg Oncol. 2017;115:68–71.CrossRefPubMed
80.
81.
Nguyen AT, Suami H. Laparoscopic free omental lymphatic flap for the treatment of lymphedema. Plast Reconstr Surg. 2015;136:114–8.CrossRefPubMed
82.
Cheng MH, et al. A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Gynecol Oncol. 2012;126:93–8.CrossRefPubMed
83.
Coriddi M, Skoracki R, Eiferman D. Vascularized jejunal mesenteric lymph node transfer for treatment of extremity lymphedema. Microsurgery. 2017;37:177–8.CrossRefPubMed
84.
Smith ML, et al. Heterotopic vascularized lymph node transfer to the medial calf without a skin paddle for restoration of lymphatic function: proof of concept. J Surg Oncol. 2017;115:90–5.CrossRefPubMed
85.
Granzow JW, Soderberg JM, Dauphine C. A novel two-stage surgical approach to treat chronic lymphedema. Breast J., 2014;20:420–2.CrossRefPubMed
86.
Brorson H. Complete reduction of arm lymphedema following breast cancer: a prospective twenty-one years’ study. Plast Reconstr Surg. 2015;136(4 Suppl):134–5.CrossRefPubMed
87.
Campisi CC, et al. Fibro-lipo-lymph-aspiration with a lymph vessel-sparing procedure to treat advanced lymphedema after multiple lymphatic-venous anastomoses: the complete treatment protocol. Ann Plast Surg. 2017. 78(2):184–190.CrossRefPubMed
88.
Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg. 1998;102:1058–67; discussion 1068.CrossRefPubMed
89.
Casley-Smith JR. Lymphedema initiated by aircraft flights. Aviat Space Environ Med. 1996;67:52–6.PubMed
90.
Graham PH. Compression prophylaxis may increase the potential for flight-associated lymphoedema after breast cancer treatment. Breast. 2002;11:66–71.CrossRefPubMed
91.
Kilbreath SL, et al. Effect of air travel on lymphedema risk in women with history of breast cancer. Breast Cancer Res Treat. 2010;120:649–54.CrossRefPubMed
92.
Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98:343–8.CrossRefPubMed
93.
Dawson WJ, et al. Elective hand surgery in the breast cancer patient with prior ipsilateral axillary dissection. Ann Surg Oncol. 1995;2:132–7.CrossRefPubMed
94.
Gharbaoui I, Netscher DT, Thornby J, et al. Safety of upper extremity surgery after prior treatment for ipsilateral breast cancer: results of an American Society for Surgery of the Hand membership survey and literature review. J Am Society Surg Hand. 2005; 5(4):232-238.CrossRef
95.
Hershko DD, Stahl S. Safety of elective hand surgery following axillary lymph node dissection for breast cancer. Breast J. 2007;13:287–90.CrossRefPubMed
96.
Ahmed RL, et al. Randomized controlled trial of weight-training and lymphedema in breast cancer survivors. J Clin Oncol. 2006;24:2765–72.CrossRefPubMed
97.
Sagen A, Karesen R, Risberg MA. Physical activity for the affected limb and arm lymphedema after breast cancer surgery: a prospective, randomized controlled trial with two years follow-up. Acta Oncol. 2009;48:1102–10.CrossRefPubMed
98.
Schmitz KH, et al. Weight-lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304:2699–705.CrossRefPubMed
99.
Kilbreath SL, et al. Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial. BMC Cancer. 2006;6:273.CrossRefPubMedPubMedCentral
100.
Johansson K, et al. Low-intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005;38:167–80.PubMed
101.
McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol. 2003;21:463–6.CrossRefPubMed
102.
Kim DS, et al. Effect of active resistive exercise on breast cancer-related lymphedema: a randomized controlled trial. Arch Phys Med Rehabil. 2010;91:1844–8.CrossRefPubMed
Metadaten
Titel
Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options
verfasst von
Sarah A. McLaughlin, MD
Sarah M. DeSnyder, MD
Suzanne Klimberg, MD, PhD
Michael Alatriste, LMT, CLT
Francesco Boccardo, MD, PhD, FACS
Mark L. Smith, MD, FACS
Alicia C. Staley, MBA, MS, BS
Paul T. R. Thiruchelvam, BSc, MD, PhD, FRCS
Nancy A. Hutchison, MD, CLT-LANA
Jane Mendez, MD
Fiona MacNeill, FRCS, MD, FEBS
Frank Vicini, MD, FACR, FABS
Stanley G. Rockson, MD
Sheldon M. Feldman, MD, FACS
Publikationsdatum
01.08.2017
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5964-6

Weitere Artikel der Ausgabe 10/2017

Annals of Surgical Oncology 10/2017 Zur Ausgabe

Breast Oncology

Contralateral Prophylactic Mastectomy with Immediate Breast Reconstruction Increases Healthcare Utilization and Cost

Breast Oncology

Nipple-Sparing Mastectomy: Pitfalls and Challenges

Breast Oncology

Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials

Breast Oncology

Socioeconomic Factors Associated with Post-Mastectomy Immediate Reconstruction in a Contemporary Cohort of Breast Cancer Survivors

Breast Oncology

Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery

Breast Oncology

Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise